Sleep Number Corporation is navigating one of the most challenging periods in its corporate history. Following a deeply disappointing quarterly earnings report, the smart-bed manufacturer is implementing an aggressive cost-cutting strategy while confronting a persistent decline in consumer demand.
Q2 2025 Financial Performance: A Detailed Look
The company’s second-quarter results for 2025 revealed a severe contraction in revenue, which plummeted by 19.7% to $328 million. This sharp decline was primarily driven by weaker sales performance and a reduced physical retail footprint. Consequently, Sleep Number posted a net loss of $25 million, or $1.09 per share, significantly underperforming against analyst forecasts.
Despite these troubling top-line numbers, one financial metric demonstrated notable resilience. The company’s gross margin held firm at 59.1%, indicating effective management of material costs and improved operational efficiency within its supply chain and delivery networks.
Aggressive Cost-Cutting Measures Take Center Stage
In response to the ongoing sales slump, management has initiated a comprehensive austerity program. Operating expenses saw a substantial reduction of $48 million compared to the same quarter last year, representing a dramatic 21% decrease.
The company has significantly raised its full-year savings target. Initially aiming for $80-100 million in cost reductions for 2025, Sleep Number now anticipates achieving approximately $130 million in savings. This strategic shift involves restructuring the entire operational framework to establish a lower cost base while maintaining product quality and customer experience standards.
Key Financial Metrics (Q2 2025):
* Revenue: $328 million (19.7% decrease)
* Net Loss: $25 million ($1.09 per share)
* Gross Margin: Remained stable at 59.1%
* Operating Expense Reduction: $48 million (21% decrease)
* 2025 Savings Target: Increased to $130 million
Should investors sell immediately? Or is it worth buying Sleep Number?
Leadership Changes and Cautious Outlook
As part of a broader organizational restructuring designed to enhance operational efficiency, Bob Ryder assumed the role of interim Chief Financial Officer in July 2025.
The full-year forecast remains cautious. Management anticipates annual revenue of approximately $1.45 billion, which would represent a 14% decrease compared to the previous year. For the second half of 2025, the company is targeting a gross margin near 61% and aims to achieve free cash flow break-even performance.
When will these strategic initiatives yield tangible results? Company leadership indicates that the full impact of their repositioning efforts—including changes to both product offerings and distribution channels—likely won’t materialize before 2026.
Market Analysts Maintain Cautious Stance
Wall Street continues to maintain a “Hold” rating on Sleep Number shares. Analyst price targets currently range between $8.33 and $10.33. With the stock trading at $9.66 as of September 3, 2025, this suggests limited near-term movement potential.
The stock’s price-to-sales multiple of 0.1x indicates potential undervaluation relative to industry peers. However, whether this valuation metric alone will attract investor interest remains uncertain. Sleep Number shares continue to represent a speculative investment within a challenging consumer market, with any meaningful turnaround expected to require considerable time.
Ad
Sleep Number Stock: Buy or Sell?! New Sleep Number Analysis from March 25 delivers the answer:
The latest Sleep Number figures speak for themselves: Urgent action needed for Sleep Number investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.
Sleep Number: Buy or sell? Read more here...
